Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 13 de 13
Filtrar
1.
Dermatol Ther ; 35(2): e15245, 2022 02.
Artigo em Inglês | MEDLINE | ID: mdl-34865278

RESUMO

Striae distensae (SD) are disfiguring skin condition causing cosmetic troubles and psychological distress. The aim was to compare the efficacy and safety of platelet-rich plasma (PRP) versus its combination with subcision or medium-depth peeling (glycolic acid 70% followed by trichloroacetic acid [TCA] 35%) for SD treatment. Seventy-five female patients with SD were divided into three equal groups with the contralateral side in each patients represented the control group. Group A treated with PRP, group B received PRP + subcision while group C received PRP + combined peeling (GA 70% + TCA 35%). Primary outcome included clinical improvement, patients' satisfaction, and Dermatology Life Quality Index (DLQI). Striae measurement, skin biopsies were also assessed. Very much improvement was achieved in 28%, 44%, and 36% in groups A, B, and C respectively. The combined groups (B and C) showed significantly higher patients' satisfaction and DLQI than group A (p = 0.03), (p < 0.0001). A significant decrease in all striae measurements was achieved with all groups (p < 0.001); however, groups B and C showed more decrease (p = 0.2 and 0.4). A highly significant decrease in the mean number of sessions was found in group B (p < 0.0001). All groups demonstrated improvement in dermal collagen deposition, which was higher in the combined groups. Side effects were mild and well tolerated. The combination of PRP with subcision or peeling was more effective and offered a higher therapeutic response than PRP alone. Moreover, the subcision has superior efficacy in striae albae and safer in darker skin types.


Assuntos
Abrasão Química , Plasma Rico em Plaquetas , Estrias de Distensão , Abrasão Química/efeitos adversos , Dermabrasão , Procedimentos Cirúrgicos Dermatológicos , Feminino , Humanos , Estrias de Distensão/terapia , Resultado do Tratamento
2.
Dermatol Surg ; 46(11): e102-e107, 2020 11.
Artigo em Inglês | MEDLINE | ID: mdl-32701529

RESUMO

BACKGROUND: Melasma is an acquired hyperpigmented skin disorder. Tranexamic acid (TXA) prevents ultraviolet radiation induced pigmentation in melasma through interfering with the plasminogen-plasmin pathway. OBJECTIVE: This study was conducted to evaluate the therapeutic effect and safety of TXA by intradermal injection versus TXA with microneedling for melasma treatment. METHODS: Fifty-six female patients with bilateral symmetrical melasma were recruited in a split-face study. All patients received an intradermal injection of TXA on one side of the face, and the other side received TXA with microneedling for 6 sessions at 2 weeks intervals. Clinical efficacy was assessed using a modified Melasma Area Severity Index (mMASI) score at the baseline and after treatment. Global photographs underwent blinded review by 2 dermatologists. Patient self-assessment and satisfaction were recorded. RESULTS: After the treatment, the mMASI score was significantly reduced compared with the baseline in both treated sides (p < .001). No significant difference between both treated sides (p > .05). Patient satisfaction was higher in the microneedling-treated side than the intradermal-injected side (p < .001). No significant adverse effects were observed in both treated sides. CONCLUSION: Intradermal injection and microneedling of TXA could be safe and effective in melasma treatment. Microneedling of TXA was significantly more satisfying to the patients.


Assuntos
Antifibrinolíticos/administração & dosagem , Agulhamento Seco/efeitos adversos , Melanose/terapia , Ácido Tranexâmico/administração & dosagem , Administração Cutânea , Adulto , Antifibrinolíticos/efeitos adversos , Terapia Combinada/métodos , Feminino , Humanos , Injeções Intradérmicas/efeitos adversos , Melanose/diagnóstico , Pessoa de Meia-Idade , Satisfação do Paciente , Índice de Gravidade de Doença , Ácido Tranexâmico/efeitos adversos , Resultado do Tratamento
3.
Dermatol Ther ; 31(3): e12591, 2018 May.
Artigo em Inglês | MEDLINE | ID: mdl-29405515

RESUMO

The aim of this study was to evaluate the safety and efficacy of Bacillus Calmette-Guerin, polysaccharide nucleic acid (BCG-PSN) therapy in the treatment of oral and cutaneous LP. Twenty-four LP patients were included in this study and classified randomly into; Oral LP group (OLP), 11 patients and Cutaneous LP group (CLP), 13 patients. All patients received intradermal injections of BCG-PSN, twice weekly for three weeks. Patients with complete response were followed up for 3 months. The assessment in OLP was based on the reduction in the treated area, (Reticulation/Erythema/Ulceration) REU scoring system and numerical rating scale (NRS). CLP evaluated by the response to treatment as (complete, partial and no response) and visual analogue scale (VAS). There were highly significant differences in the diminution of lesion areas (p < .006), NRS scores (p < .001), REU score (p < .011), and VAS (p < .001) after treatment. The majority of patients achieved complete response after 3-week management. The BCG-PNS is safe and effective in the treatment of oral and cutaneous LP.


Assuntos
Vacina BCG/uso terapêutico , Líquen Plano Bucal/tratamento farmacológico , Líquen Plano/tratamento farmacológico , Ácidos Nucleicos/uso terapêutico , Polissacarídeos Bacterianos/uso terapêutico , Adolescente , Adulto , Idoso , Vacina BCG/efeitos adversos , Criança , Feminino , Humanos , Masculino , Pessoa de Meia-Idade , Ácidos Nucleicos/efeitos adversos , Polissacarídeos Bacterianos/efeitos adversos , Adulto Jovem
4.
Dermatol Surg ; 44(5): 697-704, 2018 May.
Artigo em Inglês | MEDLINE | ID: mdl-29701622

RESUMO

BACKGROUND: Striae distensae (SD) are dermal scars associated with atrophy of the epidermis. OBJECTIVE: To evaluate the effect and safety of intralesional injection of platelet-rich plasma (PRP) versus topical tretinoin 0.05% in treatment of SD. METHODS: Thirty patients (27 females and 3 males) had bilateral striae distensae were enrolled in this study. In every patient, half of the selected striae were treated with PRP intralesional injection. The other half was treated by topical tretinoin. Skin biopsies were taken from both sides before and after the treatment. Digital photographs were taken at the baseline and at the end of follow-up period. Clinical improvement was evaluated by 2 blind dermatologists in addition to the patient's satisfaction rating. RESULTS: There was statistically significant improvement in the SD treated with PRP and topical tretinoin cream. The improvement was more in the SD treated with PRP injections (p = .015). Patient's satisfaction showed that the improvement was more in the PRP-treated side (p = .003). Collagen and elastic fibers in the dermis were increased in all biopsies after treatment. CONCLUSION: PRP injection and topical tretinoin are safe for the treatment of SD, but PRP is more effective and it gives better therapeutic response than tretinoin.


Assuntos
Fármacos Dermatológicos/administração & dosagem , Ceratolíticos/administração & dosagem , Satisfação do Paciente , Plasma Rico em Plaquetas , Estrias de Distensão/terapia , Tretinoína/administração & dosagem , Abdome/patologia , Administração Cutânea , Adolescente , Adulto , Feminino , Humanos , Injeções Intralesionais/métodos , Masculino , Pessoa de Meia-Idade , Estrias de Distensão/patologia , Coxa da Perna/patologia , Fatores de Tempo , Resultado do Tratamento , Gravação em Vídeo
5.
J Cosmet Laser Ther ; 20(6): 364-368, 2018 Oct.
Artigo em Inglês | MEDLINE | ID: mdl-29482388

RESUMO

Background: The accentuated nasolabial folds (NLFs) is the most pronounced sign of aging. Non-ablative erbium:yttrium aluminum garnet laser (ER:YAG), Smooth mode was used for the treatment of mucosal tissue. It was reported that it is effective in facial rejuvenation. Aim: To assess the safety and the effectiveness of intraoral ER:YAG Smooth mode laser in the treatment of NLFs wrinkle. Materials and methods: A total of 20 patients with different grades of NLFs wrinkle treated with 2940 nm Er:YAG laser intraorally. Six sessions were done every 2 weeks. The efficacy was assessed by two blinded dermatologists. Photographs were taken at the baseline, end of treatment and 6 months after the final session to document visible changes in NLFs wrinkle. The assessment was based on Modified Fitzpatrick Wrinkle Scale (MFWS) and by comparing the photographs. Patient's self-assessment and patient's satisfaction were used for assessment of final results and any side effects associated to treatment were observed. Results: There was significant reduction of the NLFs wrinkle. The MFWS was significantly improved 6 months after treatment compared to before treatment (p < 0.001). At the end of the follow-up period, there was improvement in overall appearance of the wrinkles. Patient's self -assessment and satisfaction demonstrated better cosmetic outcomes. Conclusion: Intraoral Er:YAG laser is safe, painless, and effective treatment option for NLFs wrinkle.


Assuntos
Técnicas Cosméticas , Lasers de Estado Sólido/uso terapêutico , Sulco Nasogeniano , Envelhecimento da Pele , Adulto , Face , Feminino , Humanos , Terapia a Laser/métodos , Lasers de Estado Sólido/efeitos adversos , Masculino , Pessoa de Meia-Idade , Mucosa Bucal , Satisfação do Paciente , Fotografação , Rejuvenescimento , Resultado do Tratamento
6.
J Dtsch Dermatol Ges ; 15(11): 1081-1088, 2017 Nov.
Artigo em Inglês | MEDLINE | ID: mdl-28981179

RESUMO

The diagnosis of Sweet's syndrome (SS) is based on a set of criteria that requires the presence of two major and at least two minor criteria. In some cases, however, the diagnosis is not as straightforward due to the absence of certain criteria. The objective of the present study was to review the clinical, histopathological, and laboratory features of the current diagnostic criteria for SS, and to evaluate their validity in the cases reported in the literature as well as in 40 patients treated at our institution. Our comprehensive review of the current criteria for SS reveals that the two major criteria have been consistently present in all cases - including ours - since the first description of SS in 1964. With regard to the minor criteria, on the other hand, there has been marked variability between different studies, and many cases failed to fulfill the requirement of showing two minor criteria. In order to simplify the diagnosis, avoid misdiagnosis, and allow for prompt treatment, we propose two sets of revised diagnostic criteria for SS. The first set comprises constant clinical and histopathological features that must be present and are by themselves sufficient for the diagnosis of SS to be established. The second set includes variable features whose absence does not warrant ruling out SS.


Assuntos
Síndrome de Sweet/diagnóstico , Corticosteroides/uso terapêutico , Adulto , Idoso , Biópsia , Diagnóstico Diferencial , Feminino , Humanos , Mediadores da Inflamação/sangue , Masculino , Pessoa de Meia-Idade , Neutrófilos/fisiologia , Pele/patologia , Síndrome de Sweet/tratamento farmacológico , Síndrome de Sweet/imunologia , Síndrome de Sweet/patologia , Resultado do Tratamento
7.
J Clin Aesthet Dermatol ; 15(10): 14, 2022 Oct.
Artigo em Inglês | MEDLINE | ID: mdl-36312826

RESUMO

[This corrects the article on p. 22 in vol. 13 PMCPMC7819592.].

8.
J Cosmet Dermatol ; 21(3): 1127-1134, 2022 Mar.
Artigo em Inglês | MEDLINE | ID: mdl-34806274

RESUMO

BACKGROUND: Acne scarring can lead to social and psychological distress. OBJECTIVE: To compare the safety, efficacy, and long-term improvement of subcision using tri-beveled hypodermic (Th) needle versus cannula for the treatment of atrophic post-acne scars. METHODS: Forty-six patients with atrophic post-acne scars were treated with subcision using (Th) needle on one side of the face and a blunt cannula on the other side of the face for 6 sessions one month apart. The primary outcome was based on the clinical improvement and patient satisfaction score. Skin biopsies were taken at baseline and 3months after the final session. Follow-up was 9 months. RESULTS: Three months after the final session, a statistically highly significant difference was detected in both sides from the baseline (p < 0.001). The overall improvement was 73.9% on the (Th) needle side versus 65.2% on the cannula side (p = 0.68). There was no significant difference in acne severity scarring grade between both sides (p = 0.86). The mean number of sessions was significantly less in the (Th) needle side (p < 0.001). Collagen deposition and reorganization were achieved with both modalities. Patient satisfaction showed no significant difference between both sides. The side effects were mild and significantly higher in the (Th) needle side (p = 0.001). CONCLUSION: Both modalities are effective and economic techniques. However, using a cannula is associated with much fewer side effects, more convenient for the patients and physicians compared to the (Th) needle.


Assuntos
Acne Vulgar , Cicatriz , Acne Vulgar/complicações , Acne Vulgar/patologia , Atrofia/complicações , Cicatriz/etiologia , Cicatriz/cirurgia , Humanos , Satisfação do Paciente , Resultado do Tratamento
9.
J Cosmet Dermatol ; 21(8): 3334-3342, 2022 Aug.
Artigo em Inglês | MEDLINE | ID: mdl-34927342

RESUMO

BACKGROUND: Acne scars are one of the most common cosmetic concerns causing psychosocial distress. OBJECTIVE: To evaluate the efficacy of subcision versus its combination with either cross-linked hyaluronic acid (HA) or poly-l-lactic acid (PLLA) threads in the treatment of atrophic post-acne scars. METHODS: Forty patients of both genders with atrophic acne scars were subjected to subcision 1 month apart for 3 sessions. After the last session of subcision, the patients were reclassified randomly into 2 equal groups each received either HA or threads in one side of the face leaving the other side that underwent subcision before as a control. Clinical assessment was carried out by the physicians and patients. Photographs and skin biopsies were obtained. Follow-up was 6 months. RESULTS: A significant clinical improvement was achieved in 67.3% of patients after subcision alone compared to 94.1%, 82.4% of subcision combined with HA or threads, respectively. Patients' satisfaction was higher in the combined groups compared to subcision alone (p < 0.0001). Side effects were tolerable and transient. CONCLUSION: Subcision combined with HA or threads could offer a higher significant clinical improvement of acne scars than subcision alone.


Assuntos
Acne Vulgar , Cicatriz , Acne Vulgar/complicações , Acne Vulgar/patologia , Atrofia/complicações , Cicatriz/etiologia , Cicatriz/patologia , Cicatriz/terapia , Terapia Combinada , Feminino , Humanos , Ácido Hialurônico/efeitos adversos , Masculino , Resultado do Tratamento
10.
J Dermatolog Treat ; 32(8): 999-1004, 2021 Dec.
Artigo em Inglês | MEDLINE | ID: mdl-32041441

RESUMO

BACKGROUND: Miconeedling has been used to augment the transdermal drug delivery. Combination modalities may accelerate and improve the repigmentation in vitiligo. OBJECTIVE: To determine the efficacy and tolerability of combined microneedling with tacrolimus vs tacrolimus 0.1% ointment for the treatment of vitiligo. PATIENTS AND METHOD: Forty-eight patients with vitiligo were randomized into two groups: group I applied tacrolimus once daily for 6 months. Group II received microneedling with topical tacrolimus at 2 weeks intervals for a maximum of 6 months. The assessment was based on the clinical improvement and immunohistochemical changes. Skin biopsies were taken at baseline and after the treatment for c-kit + expression. RESULTS: After treatment, the repigmentation >75% was observed in 50% of the patients in group II compared to 29.2% in group I (p .02). There was an earlier response in group II than in group I (p .002). The improvement was significantly higher in the legs and extremities in group II than in group I (0.003). The immunohistochemical results showed significantly higher expression of c-kit in group II than group I (p .01). No severe side effects were reported. CONCLUSION: The results suggest the superiority of the combination regimen (tacrolimus and microneedling) for vitiligo treatment.


Assuntos
Tacrolimo , Vitiligo , Administração Cutânea , Humanos , Imunossupressores/uso terapêutico , Pele , Tacrolimo/uso terapêutico , Resultado do Tratamento , Vitiligo/tratamento farmacológico
11.
J Cosmet Dermatol ; 19(4): 855-862, 2020 Apr.
Artigo em Inglês | MEDLINE | ID: mdl-32030880

RESUMO

BACKGROUND: Combination therapies have reported to augment the repigmentation in vitiligo. Microneedling (Mn) facilitates drug delivery across the skin barrier. OBJECTIVE: To evaluate and compare the efficacy and safety of Mn combined with tacrolimus vs Mn alone or tacrolimus 0.1% ointment for treatment of localized and stable vitiligo. PATIENTS AND METHOD: Ninety patients with vitiligo were randomized into three groups: group I received microneedling with tacrolimus, group II microneedling only both at 2 weeks interval for twelve sessions, and group III applied tacrolimus ointment 0.1% twice daily for 6 months. Skin biopsies were taken at baseline and after treatment. RESULTS: The overall improvement (76.6%) was significantly higher in the combined group compared with other groups. Repigmentation was excellent in 66.6 of group I vs 33.3% in the other two groups (P .03). A highly significant improvement of the extremities was observed in the combined group than in the other groups (P < .001). A fewer number of sessions have reported in the combined group (I) than in the microneedling group (II; P < .001). Immunohistochemical results showed a significantly higher expression of HMB-45 in group I than in other two groups (P .04). Side effects were mild and tolerable in all groups. CONCLUSION: The combination group has shown promising results over the other two groups.


Assuntos
Agulhamento Seco/métodos , Imunossupressores/administração & dosagem , Tacrolimo/administração & dosagem , Vitiligo/terapia , Administração Cutânea , Adolescente , Adulto , Criança , Terapia Combinada/métodos , Feminino , Humanos , Masculino , Pessoa de Meia-Idade , Pomadas , Pigmentação da Pele/efeitos dos fármacos , Resultado do Tratamento , Vitiligo/diagnóstico , Adulto Jovem
12.
J Clin Aesthet Dermatol ; 13(12): 22-26, 2020 Dec.
Artigo em Inglês | MEDLINE | ID: mdl-33488914

RESUMO

BACKGROUND: Intradermal botolinum toxin A (BTXA) is an advanced technique that emerged in response to the increased demand for noninvasive facial lifting and skin rejuvenation. OBJECTIVE: We sought to evaluate the safety and efficacy of intradermal injections of BTXA for facial lifting. METHODS: Twenty-five female patients with mild symmetrical facial skin laxity were enrolled in this study. All patients were treated with BTXA in one side of the face while the other side was injected with normal saline. The response to treatment was assessed by two dermatologists who evaluated global photographs using a quartile grading scale (QGS). The patient self-assessment and satisfaction questionnaires were recorded. RESULTS: A highly significant difference was found between the side injected with BTXA and the saline injected side (control) (p<0.001). Facial lifting was achieved in 58.66 percent of the sides injected with BTXA. Forty-four percent of patients were very satisfied. Older patients showed better improvement than younger patients (p=<0.001). The results persisted for 16 weeks. No adverse effects were observed. CONCLUSION: Our results suggest that intradermal injection of BTXA could be a safe and effective therapeutic option for face lifting.

13.
J Cosmet Dermatol ; 18(5): 1456-1462, 2019 Oct.
Artigo em Inglês | MEDLINE | ID: mdl-31074201

RESUMO

BACKGROUND: Alopecia areata (AA) is nonscarring patchy area of hair loss. Platelets rich plasma (PRP) promotes development of new hair follicles. Dermoscopy is a diagnostic tool that helps in evaluation of skin microstructures which are not visible to naked eye. AIM: To evaluate safety and efficacy of (PRP) vs intralesional corticosteroid (ILCs) in treatment of AA. PATIENTS AND METHODS: This study was conducted on 80 patients of both sexes who had AA. Patients were classified into Group I treated by ILCs and group II treated by (PRP). Results were assessed by dermoscopic evaluation and by hair re-growth score (RGS) at (baseline), 2, 4, 6, 8, and 12 weeks. Patients were followed up for 6 months. RESULTS: There was greater hair re-growth after treatment in both groups. In group I, (26) patients (65%) showed improvement >70% compared to 29 patients (72.5%) in group II. There was significant re-growth of pigmented hair and decrease in dystrophic hair (P < 0.001) by dermoscopic evaluation in both groups. The difference between both groups was insignificant (P = 0.57). At follow-up, two (5%) patients in group II had relapse compared to 10 (25%) patients in group I. CONCLUSION: Platelets rich plasma is safe and promising therapeutic option in AA.

SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA